Oxify Cream
FDA Label NDC 11383-003

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Weeks & Leo Compnay, Inc. for the product Oxify (NDC 11383-003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - ask doctor, otc - keep out of reach of children, otc - pregnancy or breast feeding, otc - purpose, otc - questions, otc - stop use, otc - when using, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.